Eli Lilly and Company

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

31 May 2009

The primary objective of this study is to estimate the incidence of new-onset valvulopathy, determined by baseline and follow-up echocardiograms, in patients with Parkinson's Disease who are ...

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

15 Feb 2007

This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label fashion, in depressed patients with Parkinson's disease during 12 weeks treatment. ...

Latest Discussions

MJFF Closed Next Week
Members in the News: Charleen T. Chu Receives Outstanding Investigator Award

Responses: 1
Cognitive Problems May Precede PD Motor Symptoms

Responses: 1
Systems Approaches to Parkinson's Disease

Responses: 15
Federal Funding of Embryonic Stem Cells Halted

Responses: 1

MJFF Closed Next Week

27 Aug 2010

MJFF is closed next week, but news will be back up after Labor Day! ...
Gila Monster Venom Trial to Treat PD Underway in U.K.

27 Aug 2010

Researchers at University College London Hospitals (U.K.) are starting a clinical trial to test Exenatide, a synthetic version of a compound originally found in Gila monster saliva. MJFF has funded ...
NIH Director Collins Speaks about Stem Cell Ruling

26 Aug 2010

According to an article in The Scientist, NIH Director Francis Collins says that he was "stunned" by the recent ruling halting research on embryonic stem cells. ...
Members in the News: Charleen T. Chu Receives Outstanding Investigator Award

26 Aug 2010

The American Society for Investigative Pathology has given Charleen T. Chu, associate professor at the University of Pittsburgh, their Outstanding Investigator Award. In a recent paper published in ...

EMBO/EMBL Symposium: Structure and Function of Neural Circuits

05 Sep 2010 - 08 Sep 2010
Autophagy: From Molecules to Disease

08 Sep 2010 - 12 Sep 2010
2010 World Molecular Imaging Congress

08 Sep 2010 - 11 Sep 2010

RFP: Novel Biomarkers to Accelerate Drug Discovery for Frontotemporal Dementias

Institution: The Association for Frontotemporal Dementias

Submission deadline: 09 Sep 2010
2011 NIH Director’s Pioneer Award Program (DP1)

Institution: National Institutes of Health (NIH)

Submission deadline: 13 Sep 2010
Clinical and Basic Research: Parkinson's Disease and Dystonia

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010
Dekker RFP: Clinical Aspects of Parkinson's Disease

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010
Dystonia RFP

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010

Eli Lilly and Company

Latest Discussions

Latest News

Upcoming Events

Funding Opportunities